Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Total World Stock Index Fund ETF (VT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Total World Stock Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $41, while Vanguard Total World Stock Index Fund ETF trades at $156.8. Which is the better fit depends on your goals.
| ARKG | VT | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $159.35 |
52-Week Low | $23.09 | $128.41 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Vanguard Total World Stock ETF (VT) trades at $157.63, up 0.4% with a bullish technical outlook from moving averages. The ETF maintains global diversification with over 10,000 holdings across developed and emerging markets. Recent news highlights competitive positioning against peers like SPDW and SCHF, with a modest 1.6% dividend yield and low 0.06% expense ratio. Technical indicators show support at $155 and resistance at $159, with RSI levels in neutral territory.
VT offers broad global equity exposure with cost efficiency, though emerging market volatility and currency risks persist. The ETF's neutral oscillator signals and mixed ADX readings suggest near-term consolidation potential. Long-term growth hinges on global economic stability and diversification benefits outweighing sector-specific downturns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →
